Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 10, Number 1—January 2004
Research

Respiratory and Urinary Tract Infections, Arthritis, and Asthma Associated with HTLV-I and HTLV-II Infection

Edward L. Murphy*, Baoguang Wang†, Ronald A. Sacher‡, Joy Fridey§, James W. Smith¶, Catharie C. Nass#, Bruce Newman**, Helen E. Ownby**, George Garratty††, Sheila T. Hutching††, and George B. Schreiber†
Author affiliations: *University of California San Francisco, California, USA; †Westat, Rockville, Maryland, USA; ‡Hoxworth Blood Center, Cincinnati, Ohio, USA; §Blood Bank of San Bernardino and Riverside Counties, San Bernardino, California, USA; ¶Oklahoma Blood Institute, Oklahoma City, Oklahoma, USA; #American Red Cross Blood Services Chesapeake and Potomac, Baltimore, Maryland, USA; **American Red Cross Blood Services Southeastern Michigan, Detroit, Michigan, USA; ††American Red Cross Blood Services Southern California, Los Angeles, California, USA

Main Article

Table 3

Incidence density (ID)a and standard deviation (SD) of medically diagnosed infectious diseases, and selected crude and adjusted rate ratios (RR), among human T-lymphotropic virus (HTLV)-I– and HTLV-II–infected participants and HTLV-seronegative participants, visits 2 and 3

Diagnosis HTLV seronegative 
(N = 799) HTLV-I (N = 152) HTLV-II (N = 387)
ID (SD) ID (SD) RRb Adj. RR (95% CI)c ID (SD) RRb Adj. RR (95% CI)c
Pneumonia 0.08 (0.37) 0.11 (0.47) 1.49 1.33 (0.66 to 2.66) 0.21 (0.96) 2.82 2.65 (1.67 to 4.21)
Acute Bronchitis 0.59 (1.78) 0.82 (2.25) 1.38 1.33 (0.84 to 2.12) 1.10 (2.75) 1.83 1.53 (1.10 to 2.14)
Bladder or Kidney infection 0.63 (2.04) 1.75 (4.61) 2.73 2.32 (1.50 to 3.59) 1.25 (3.48) 1.94 1.94 (1.40 to 2.68)

aDefined as the mean of the total number of infectious disease diagnoses divided by the number of participants (with or without the infection) in each group at baseline. The period of observation was 4.4 years (HTLV-I), 4.3 years (HTLV-II), and 4.4 years (HTLV seronegative), and each participant may have multiple diagnoses of each condition.bUnadjusted.
cAdjusted. Adjusted models included age, gender, race/ethnicity and duration of follow-up for all infections, and injection drug use (for pneumonia), smoking (for acute bronchitis), and community versus autologous blood donation (for bladder/kidney infection).

Main Article

Page created: December 21, 2010
Page updated: December 21, 2010
Page reviewed: December 21, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external